Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study - Pan, Shida; Wang, Jianing; Tian, Jiahe; Wang, Yilin; Wang, Siyu; Yu, Yingying; Li, Fengyi; Jiao, Yan-Mei; Shen, Yingjuan; Yang, Luo; Liu, Xiaomeng; Qiu, Qin; et al. (Frontiers in Immunology, 2025)